Compare Avalanche Treasury Corporation Class A Common Stock (AVAT) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalanche Treasury Corporation Class A Common Stock vs 10X Genomics Inc — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $15.33M), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 496.4× Avalanche Treasury Corporation Class A Common Stock's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Avalanche Treasury Corporation Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| AVAT | TXG | |
|---|---|---|
Market Cap | $15.33M | $7.61B |
Sector | Financials | Health |
52-Week High | $10.75 | $58.57 |
52-Week Low | $0.30 | $11.34 |
Enterprise Value | $15.33M | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
